Selected Publications
Friedman Flack K, George M, Podolanczuk A, Kim J, Hoffman E, Johnson C, McGroder C, Smith B, Garcia C, Kreider M, Kawut S, Barr R.G, Anderson M, Bernstein E.: Antinuclear antibodies and progression of high attenuation areas on chest computed tomography: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. American Thoracic Society : 2023.
Friedman Flack K & Katzen J.: Revealing the rare: Pulmonary fibrosis from surfactant-related gene mutation. CHEST. 163 (4): 744-745,2023.
Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson M, Hoffman E, Podolanczuk A, Yun J, McDermott G, Sparks J, Moll M, Rich S, Rotter J, Noth I, Ragu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake G, Cho M, Garcia C, Barr R.G, Bernstein E.: Association of rheumatoid arthritis-related antibodies, HLA-DRB1, and MUC5B (rs35705950) with high attenuation areas, forced vital capacity, and interstitial lung abnormalities. International Colloquium on Lung and Airway Fibrosis
: 2022.
Friedman Flack, K., Gao, G.M., Berstein, E., Johnson, C., Diamond, J., Benvenuto, L. Arcasoy, S., Greeland, J., Betancourt, L., Oyster, M., Brown, M., Kalman, L., Zaleski, D., Adler, J., Tevald, M., Balar, P., Patel, S., Medikonda, N., Kreider, M., Christie, J., Singer, J., Anderson, M.: Differences in body composition and frailty between lung transplant candidates with connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis. American Thoracic Society : 2022.
Friedman Flack K, Grimm J, Haas A, Jarrar D, Szeto W, Palevsky H.: Massive hemoptysis secondary to an aortomediastinoparenchymal fistula. American Thoracic Society International Conference. : 2020.
Friedman Flack K, Chu S, Ciunci C, Berman A, Kreider M, Porteous M.: The management and outcomes of patients with both interstitial lung disease and lung cancer. American Thoracic Society International Conference. Dallas, TX : 2019.
Kolb JM*, Friedman Flack K*, Chatterjee-Murphy P, Desai J, Wallentin L, Ezekowitz M, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J., *co-first authors: Locations and mucosal lesions responsible for major gastrointestinal bleeding in patients on warfarin or dabigatran. Dig Dis Sci. 63 (7): 1878-1889,2018.
Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz J, Ruff C, Nordio F, Mercuri M, Choi Y, Antman E, Braunwald E, Giugliano R.: Gastrointestinal bleeding with edoxaban versus warfarin: Results from the ENGAGE AF- TIMI 48 trial. Circ Cardiovasc Qual Outcomes 11 (5): epub,2018.
Romanoff A, Schmidt H, McMurray M, Weltz C, Schwartzman M, Friedman K, Margolies L, Port E.: Who is ordering MRIs in newly diagnosed breast cancer patients? Am Surg. 84 (3): 351-357,2018.
Friedman Flack K, Desai J, Kolb JM, Chatterjee P, Wallentin L, Ezekowitz M, Yusuf S, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J.: Major gastrointestinal bleeding is often caused by occult malignancy in patients receiving warfarin or dabigatran to prevent stroke and systemic embolism from atrial fibrillation. Clin. Gastroenterol. Hepatol. 15 (5): 682-690,2017.
Academic Contact Information
3600 Spruce Street
Philadelphia,
PA
19104
Patient appointments: 800-789-7366